Literature DB >> 25713403

What does it mean to be 'amyloid-positive'?

Anne M Fagan1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25713403      PMCID: PMC4408431          DOI: 10.1093/brain/awu387

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  11 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

4.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Authors:  Anne M Fagan; Mark A Mintun; Robert H Mach; Sang-Yoon Lee; Carmen S Dence; Aarti R Shah; Gina N LaRossa; Michael L Spinner; William E Klunk; Chester A Mathis; Steven T DeKosky; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

5.  Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.

Authors:  Joseph M Castellano; Jungsu Kim; Floy R Stewart; Hong Jiang; Ronald B DeMattos; Bruce W Patterson; Anne M Fagan; John C Morris; Kwasi G Mawuenyega; Carlos Cruchaga; Alison M Goate; Kelly R Bales; Steven M Paul; Randall J Bateman; David M Holtzman
Journal:  Sci Transl Med       Date:  2011-06-29       Impact factor: 17.956

6.  Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

Authors:  R Motter; C Vigo-Pelfrey; D Kholodenko; R Barbour; K Johnson-Wood; D Galasko; L Chang; B Miller; C Clark; R Green
Journal:  Ann Neurol       Date:  1995-10       Impact factor: 10.422

7.  Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.

Authors:  Niklas Mattsson; Philip S Insel; Michael Donohue; Susan Landau; William J Jagust; Leslie M Shaw; John Q Trojanowski; Henrik Zetterberg; Kaj Blennow; Michael W Weiner
Journal:  Brain       Date:  2014-12-24       Impact factor: 13.501

8.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

9.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  Revising the definition of Alzheimer's disease: a new lexicon.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T Dekosky; Pascale Barberger-Gateau; André Delacourte; Giovanni Frisoni; Nick C Fox; Douglas Galasko; Serge Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2010-10-09       Impact factor: 44.182

View more
  7 in total

Review 1.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

Review 2.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 3.  Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics.

Authors:  Aaron Ritter; Jeffrey Cummings
Journal:  Front Neurol       Date:  2015-08-31       Impact factor: 4.003

4.  Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.

Authors:  Antoine Leuzy; Konstantinos Chiotis; Steen G Hasselbalch; Juha O Rinne; Alexandre de Mendonça; Markus Otto; Alberto Lleó; Miguel Castelo-Branco; Isabel Santana; Jarkko Johansson; Sarah Anderl-Straub; Christine A F von Arnim; Ambros Beer; Rafael Blesa; Juan Fortea; Sanna-Kaisa Herukka; Erik Portelius; Josef Pannee; Henrik Zetterberg; Kaj Blennow; Agneta Nordberg
Journal:  Brain       Date:  2016-07-07       Impact factor: 13.501

5.  Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer's Disease and Frontotemporal Dementia.

Authors:  Giulia Giacomucci; Salvatore Mazzeo; Silvia Bagnoli; Matteo Casini; Sonia Padiglioni; Cristina Polito; Valentina Berti; Juri Balestrini; Camilla Ferrari; Gemma Lombardi; Assunta Ingannato; Sandro Sorbi; Benedetta Nacmias; Valentina Bessi
Journal:  J Pers Med       Date:  2021-01-14

6.  Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer's Disease.

Authors:  Murray Andrews; Ryan Ross; Atul Malhotra; Sonia Ancoli-Israel; James B Brewer; Sarah J Banks
Journal:  J Alzheimers Dis Rep       Date:  2021-01-20

7.  Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.

Authors:  Ruth Stephen; Yawu Liu; Tiia Ngandu; Juha O Rinne; Nina Kemppainen; Riitta Parkkola; Tiina Laatikainen; Teemu Paajanen; Tuomo Hänninen; Timo Strandberg; Riitta Antikainen; Jaakko Tuomilehto; Sirkka Keinänen Kiukaanniemi; Ritva Vanninen; Seppo Helisalmi; Esko Levälahti; Miia Kivipelto; Hilkka Soininen; Alina Solomon
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.